Δημοσιεύσεις
Improvement of Calcinosis in Dermatomyositis With Intravenous Immunoglobulin
Sakellariou GT, Katsigianni I
J Clin Rheumatol 2024;30:e124
Effect of secukinumab on bone formation markers in patients with active ankylosing spondylitis
Sakellariou GT, Konsta M, Katsigianni I, Deligeorgakis D, Zisopoulos D, Vounotrypidis P
Int J Rheum Dis 2023;26:2603-2606
Follow-up imaging of SAPHO syndrome treated with denosumab
Sakellariou GT, Chaitidis N, Tsifountoudis I
Rheumatology (Oxford) 2023;62:e357-e358
Pustulotic arthro-osteitis (Sonozaky syndrome)
Sakellariou GT, Tsifountoudis I
Eur J Rheumatol 2022;9:180-181
A case of Behçet’s disease with scleromalacia perforans
G.Sakellariou, C.Berberidis, P.Vounotrypidis
Rheumatology(Oxford) 2005;44:258-260
Infusion related reactions to infliximab in patients with rheumatoid arthritis
G.T.Sakellariou, I.Chatzigiannis
J Rheumatol 2005;32:1411-1412
Infliximab infusions for persistent back pain in two patients with Schmorl’s nodes
G.T.Sakellariou, I.Chatzigiannis, I.Tsitouridis
Rheumatology(Oxford) 2005;44:1588-1590
Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra)
P.Vounotrypidis, G.T.Sakellariou, D.Zisopoulos, C.Berberidis
Rheumatology(Oxford) 2006;45:491-492
Bone density in young males with recently diagnosed inflammatory bowel disease
G.T.Sakellariou, J.Moschos, C.Berberidis, A.Mpoumponaris, S.Kadis, E.Molyvas, G.Kouklakis
Joint Bone Spine 2006;73:725-728
Intraarticular injection of infliximab
G.T.Sakellariou, G.Kakavouli, I.Chatzigiannis
J Rheumatol 2006;33:1912-1913
Long-term anti-TNFα therapy for ankylosing spondylitis in two patients with chronic HBV infection
G.T.Sakellariou, I.Chatzigiannis
Clin Rheumatol 2007;26:950-952
Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy
G.T.Sakellariou, P.Vounotrypidis, C.Berberidis
Clin Rheumatol 2007;26:1132-1133
No Effect of rosuvastatin in the zoledronate-induced acute-phase response
P.Makras, A.D.Anastasilakis, S.A.Polyzos, I.Bisbinas, G.T.Sakellariou, S.E.Papapoulos
Calcif Tissue Int 2011;88:402-408
Extensive calcinosis in lupus panniculitis
G.T.Sakellariou, D.Karanikolas, G.A.Kapetanos, K.Koutroumanidis, C.Berberidis
Arthritis Rheum 2011;63:2743
Efficacy of leflunomide addition in relation to prognostic factors for patients with active early rheumatoid arthritis failing to methotrexate in daily practice
G.T.Sakellariou, F.E.Sayegh, G.A.Kapetanos, C.Berberidis
Clin Rheumatol 2012;31:163-167
Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass
A.D.Anastasilakis, S.A.Polyzos, P.Makras, G.T.Sakellariou, I.Bisbinas, A.Gkiomisi, S.Delaroudis, S.Gerou, I.Ballaouri, D.Oikonomou, S.E.Papapoulos
Bone 2012;50:1130-1134
Central skeletal sarcoidosis: a case report with sustained remission only on methotrexate, and a literature review on the imaging approach, treatment, and assessment of disease activity
G.T.Sakellariou, A.D.Anastasilakis, D.Karanikolas, P.Vounotrypidis, C.Berberidis
Mod Rheumatol 2013;23:175-181
Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexate
G.T.Sakellariou, F.E.Sayegh, A.D.Anastasilakis, G.A.Kapetanos
Rheumatol Int 2013;33:2917–2920
Disease-modifying anti-rheumatic drugs for refractory severe knee synovitis in patients with peripheral spondyloarthritis: efficacy and predictors of response
G.T.Sakellariou, F.E.Sayegh, A.D.Anastasilakis, I.Bisbinas, G.A.Kapetanos
Scand J Rheumatol 2013;42:369–372
Pachymeningitis in granulomatosis with polyangiitis: a case report and a review of the literature
G.T.Sakellariou, N.Kefala
Case Reports in Rheumatology 2013, ArticleID 840984
Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment
A.D.Anastasilakis, S.A.Polyzos, P.Makras, M.Savvides, G.T.Sakellariou, A.Gkiomisi, A.Papadopoulou, E.Terpos
Horm Metab Res 2014;46:145-149
Circulating periostin levels in patients with ankylosing spondylitis: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation
G.T.Sakellariou, A.D.Anastasilakis, I.Bisbinas, D.Oikonomou, S.Gerou, S.A.Polyzos, F.E.Sayegh
Rheumatology(Oxford) 2015;54:908-914
Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment
A.D.Anastasilakis, S.A.Polyzos, P.Makras, A.Gkiomisi, G.Sakellariou, M.Savvidis, A.Papatheodorou, P.Kokkoris, E.Terpos
Expert Opin Ther Targets 2015;19:299-306
Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk
E.Kenanidis, M.E.Potoupnis, P.Kakoulidis, A.Leonidou, G.T.Sakellariou, F.E.Sayegh, E.Tsiridis
Expert Opin Drug Saf 2015;14:1035-1053
Denosumab versus zoledronic acid in patients previously treated with zoledronic acid
A.D.Anastasilakis, S.A.Polyzos, A.Gkiomisi, Z.G.Saridakis, D.Digkas, I.Bisbinas, G.T.Sakellariou, A.Papatheodorou, P.Kokkoris, P.Makras
Osteoporos Int 2015;26:2521-2527
Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease
S.A.Polyzos, A.D.Anastasilakis, J.Kountouras, P.Makras, A.Papatheodorou, P.Kokkoris, G.T.Sakellariou, E.Terpos
J Bone Miner Metab 2016;34:447-456
Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers
A.D.Anastasilakis, S.A.Polyzos, Z.A.Efstathiadou, M.Savvidis, G.T.Sakellariou, A.Papatheodorou, P.Kokkoris, P.Makras
Metabolism 2015;64:1291-1297
The effect of smoking on clinical and radiographic variables, and acute phase reactants in patients with ankylosing spondylitis
G.T.Sakellariou, A.D.Anastasilakis, E.Kenanidis, M.Potoupnis, E.Tsiridis, M.Savvidis, N.Kartalis, F.E.Sayegh
Rheumatol Int 2015;35:2109-2114
Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters
G.T.Sakellariou, A.Iliopoulos, M.Konsta, E.Kenanidis, M.Potoupnis, E.Tsiridis, E.Gavana, F.E.Sayegh
Joint Bone Spine 2017;84:309-315
Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment
A.D.Anastasilakis, M.P.Yavropoulou, P.Makras, G.T.Sakellariou, F.Papadopoulou, S.Gerou, S.E.Papapoulos
Eur J Endocrinol 2017;176:677-683
Grab the bull by the horns
G.T.Sakellariou, I.Tsifountoudis, P.Athanassiou
J Clin Rheumatol 2018;24:149-150
Vascular acrosyndromes in young adult population. Definition of clinical symptoms and connections to joint hypermobility
P.Vounotrypidis, A.Pyrpasopoulou, G.T.Sakellariou, D.Zisopoulos, N.Kefala, D.I.Oikonomou, C.Stefanis, S.Aslanidis, C.Bermperidis, P.Pappas
Clin Rheumatol 2019;38:2925-2932
Long-term effect of TNF inhibitors on radiographic progression in ankylosing spondylitis is associated with time-averaged CRP levels
M.Konsta, G.T.Sakellariou, T.Rusman, P.P.Sfikakis, A.Iliopoulos, I.E. van der Horst-Bruinsma
Joint Bone Spine 2021;88:105-111
Psoriatic onycho-pachydermo periostitis (POPP): a case report treated successfully with IL-17 blockade and a literature review on characteristics, pathogenesis, and treatment
G.T.Sakellariou, I.Tsifountoudis, P.Vounotrypidis
Clin Rheumatol 2021 Apr 8 [in press]